Safety and Efficacy Study in the Treatment of Intestinal Problems Associated With Autism
Status:
Unknown status
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if human immunoglobulin given by mouth twice a day
is effective in treating the persistent gastrointestinal (GI) problems such as diarrhea,
constipation, abdominal pain, and bloating, in children with autism.